SBIR-involved only briefly in its earliest years, the firm formerly known as Amyris Biotechnologies Inc, became Amyris, Inc (NASDAQ:AMRS) and changed the focus of the firm from biotech instead to become an integrated renewable products company, providing alternatives to a range of petroleum-sourced products used in specialty chemical and transportation fuel markets worldwide. Soon after acquiring another SBIR firm - Draths Corporation (in 2011) the firm went public in the Fall 2012. The firm organizes around creating renewable products focus on fuels and chemicals that provide no-compromise sustainable alternatives to a broad range of petroleum-sourced products. The company uses an industrial synthetic biology platform that applies its innovative bioscience solutions to convert plant sugars into hydrocarbon molecules and produce specialty ingredients and consumer products. Its technology creates products that support biopharmaceutical drug discovery and production, from cosmetic emollients and fragrances to fuels, solvents, lubricants, and nutraceuticals.
